Large-scale testing (Phase 3)UnknownNCT02409199What this trial is testingApatinib Versus Docetaxol Patients With Advanced Gastric CancerWho this might be right forGastric Carcinoma Shanghai Zhongshan Hospital 66
Early research (Phase 1)Study completedNCT04513223What this trial is testingSHR-A1811 in Patients With Selected HER2 Expressing TumorsWho this might be right forGastric CancerColorectal Cancer Jiangsu HengRui Medicine Co., Ltd. 101
Large-scale testing (Phase 3)Looking for participantsNCT04342910What this trial is testingStudy to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJCWho this might be right forGastric Cancer Jiangsu HengRui Medicine Co., Ltd. 550
Not applicableLooking for participantsNCT06846996What this trial is testingReal-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in ChinaWho this might be right forHER2-positive Gastric CancerHER2-positive Gastroesophageal Junction Daiichi Sankyo 260
Large-scale testing (Phase 3)Looking for participantsNCT07315750What this trial is testingDisitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.Who this might be right forGastric Carcinoma RemeGen Co., Ltd. 555
Early research (Phase 1)Not Yet RecruitingNCT07358884What this trial is testingFirst in Human Study of QLS5316 in Solid TumorsWho this might be right forSolid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more Qilu Pharmaceutical Co., Ltd. 300
Large-scale testing (Phase 3)Looking for participantsNCT07043400What this trial is testingInvestigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forMetastatic Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma BeOne Medicines 351
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Carcinoma RemeGen Co., Ltd. 616
Testing effectiveness (Phase 2)Study completedNCT00737373What this trial is testingOxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus CancerWho this might be right forGastric CancerAdenocarcinoma of the Esophagogastric Junction Krankenhaus Nordwest 143
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586294What this trial is testingAnti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma Akeso 294
Large-scale testing (Phase 3)UnknownNCT05919381What this trial is testingGentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.Who this might be right forAdenocarcinoma of Stomach Changchun GeneScience Pharmaceutical Co., Ltd. 752
Testing effectiveness (Phase 2)Study completedNCT03141034What this trial is testingRamucirumab Plus Irinotecan for Previously Treated Advanced Gastric or Gastro-esophageal Junction AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastro-esophageal Junction Adenocarcinoma Washington University School of Medicine 40
Testing effectiveness (Phase 2)Study completedNCT01611857What this trial is testingPhase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or StomachWho this might be right forMalignant Solid TumourGastroesophageal Cancer SCRI Development Innovations, LLC 49
Testing effectiveness (Phase 2)Study completedNCT03686488What this trial is testingTAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaWho this might be right forGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 23
Large-scale testing (Phase 3)Study completedNCT00680901What this trial is testingLOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus LapatinibWho this might be right forNeoplasms, Gastrointestinal Tract Novartis Pharmaceuticals 545
Early research (Phase 1)Study completedNCT04805307What this trial is testingSafety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901Who this might be right forAdvanced Solid TumorGastric Cancer(Including Gastroesophageal Junction Adenocarcinoma)Pancreatic Cancer Keymed Biosciences Co.Ltd 176
Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Large-scale testing (Phase 3)UnknownNCT01015339What this trial is testingPaclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric JunctionWho this might be right forAdvanced Gastric Cancer Peking University 320
Not applicableUnknownNCT04915807What this trial is testingReal-world Data (RWD) of Ramucirumab Plus PaclitaxelWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Hallym University Medical Center 222
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115